EngagINg the COmmunity to Reduce Preterm birth via Adherence To an Individualized Prematurity Prevention Plan (INCORPorATe IP3): intervention development and future pilot study design.

Dr. Sarahn M. Wheeler is a practicing maternal-fetal medicine specialist at Duke University Medical Center. Dr. Wheeler was born and raised in Mt. Laurel, NJ. She graduated magna cum laude from Harvard University. She completed medical school at the University of Chicago’s Pritzker School of Medicine. Dr. Wheeler went on to residency training in Obstetrics and Gynecology at the Johns Hopkins Hospital. Dr. Wheeler completed her maternal-fetal medicine sup-specialty training at Duke University in June of 2016.

Dr. Wheeler currently serves as Assistant Professor in the Duke University School of Medicine. In this role, Dr. Wheeler is both a practicing clinician and research faculty. in her clinical role, Dr. Wheeler is the director of Duke's Prematurity Prevention Program, a specialty clinic that is geared for women with risk factors for preterm birth.  In her research role, Dr. Wheeler has published several peer-reviewed articles on topics ranging from fetal brain injury to vaccination during pregnancy. Dr. Wheeler’s current research focus is on race disparities in preterm birth. She is actively involved in research to develop interventions to improve utilization of preterm birth prevention therapies.

Dr. Wheeler also serves as the Director of Diversity, Equity and Inclusion for the OB/GYN department.  In this role she leads efforts to ensure an inclusive environment for the diverse patients, faculty, staff and trainees within Duke OB/GYN.

Dr. Amy Corneli, a social scientist by training, conducts qualitative, mixed-method, intervention, and implementation science research. Her work spans the U.S. and multiple countries in sub-Saharan Africa, the Middle East, and South and Southeast Asia. She has a history of collaborating with and learning from community organizations and representatives in conducting research with populations that face discrimination, bias, or unequal treatment within the healthcare system and society due to race, ethnicity, gender, sexual orientation, or socioeconomic status. Her collaborative research often focuses on generating synergies between the creativity of art and the analytical thinking of science. The findings from her research inform clinical trials and practice, socio-behavioral interventions, guideline development, and the practical dissemination of proven interventions.

Dr. Corneli's current research portfolio encompasses three areas:

1. Leading, co-leading, mentoring, and supporting qualitative, mixed-methods, and implementation science research in HIV prevention.
2. Serving as a methodological investigative partner on qualitative, mixed-methods, and intervention research on a variety of health conditions and topics with faculty in the School of Medicine at Duke University.
3. Leading the social science team for the Clinical Trials Transformation Initiative, a public-private initiative between Duke University and the U.S. Food and Drug Administration.

Dr. Corneli is also the:

1. Founder and Director of QualCore, a group of PhD- and master-level social scientists who partner with Duke faculty to provide scientific direction and interviewing and analysis expertise in qualitative research.
2. Co-founder and Director of The BASE (Bioethics and Stakeholder Engagement) Lab, a group of faculty and staff that partner with clinical investigators at Duke to conduct research with key contributors to inform the planning, conduct, interpretation, and reporting of clinical research.
3. Director of the Duke CFAR Social and Behavioral Sciences Core.

QualCore | https://populationhealth.duke.edu/research/qualcore

The BASE Lab | https://populationhealth.duke.edu/research/base-lab

Duke CFAR Social and Behavioral Sciences Core | https://cfar.duke.edu 

Clinical Trials Transformation Initiative | https://www.ctti-clinicaltrials.org 

Prior to joining Duke University, Dr. Corneli was engaged in biomedical HIV prevention research at FHI 360 for 10 years.

Dr. Bosworth is a health services researcher and Deputy Director of the Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)  at the Durham VA Medical Center. He is also Vice Chair of Education and Professor of Population Health Sciences. He is also a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities. 

Dr. Bosworth is the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of self-management, Dr. Bosworth has expertise developing interventions to improve health behaviors related to hypertension, coronary artery disease, and depression, and has been developing and implementing tailored patient interventions to reduce the burden of other chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and use members of the healthcare team, particularly pharmacists and nurses. He has been the Principal Investigator of over 30 trials resulting in over 400 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Medicaid of North Carolina, private payers, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs.

Areas of Expertise: Health Behavior, Health Services Research, Implementation Science, Health Measurement, and Health Policy